4//SEC Filing
Baldry Mark 4
Accession 0001628280-25-026864
CIK 0001501697other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:51 PM ET
Size
4.9 KB
Accession
0001628280-25-026864
Insider Transaction Report
Form 4
Baldry Mark
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2025-05-16$2.48/sh+1,032$2,561→ 25,337 total
Footnotes (1)
- [F1]On May 16, 2025, the Reporting Person purchased shares of common stock through the Issuer's Amended and Restated 2017 Employee Stock Purchase Plan at a price of $2.482 per share.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001644137
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:51 PM ET
- Size
- 4.9 KB